Evident Technologies Licenses IBM Quantum Dots
TROY, N.Y., June 2 -- Evident Technologies today announced it has entered into a license agreement with IBM for lead selenide (PbSe) quantum dots. This license enables Evident Technologies to make, use, offer to sell and sell PbSe nanocrystals based on IBM's production methods. As part of the agreement, Evident will provide materials produced under the agreement to IBM, and IBM will provide consulting services to Evident.
Clinton Ballinger, CEO of Evident Technologies, said, "We know that quantum dot nanocrystals offer benefits to a whole plethora of applications, ranging from lasers to lighting to photonics. These materials have been rare and hard to obtain in the past. By making these materials commercially available, a wealth of applications for quantum dots can move out of the research lab and into practical devices and products."
For more information, visit: www.evidenttech.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024